» Articles » PMID: 29077004

The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Oct 28
PMID 29077004
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases are the leading cause of mortality worldwide. Therefore, a better understanding of their pathomechanisms and the subsequent implementation of optimal prophylactic and therapeutic strategies are of utmost importance. A growing body of evidence states that low-grade inflammation is a common feature for most of the cardiovascular diseases in which the contributing factors are the activation of toll-like receptors (TLRs) and vitamin D deficiency. In this article, available data concerning the association of cardiovascular diseases with TLRs and vitamin D status are reviewed, followed by a discussion of new possible approaches to cardiovascular disease management.

Citing Articles

The Role of TLRs in Obesity and Its Related Metabolic Disorders.

Campos-Bayardo T, Roman-Rojas D, Garcia-Sanchez A, Cardona-Munoz E, Sanchez-Lozano D, Totsuka-Sutto S Int J Mol Sci. 2025; 26(5).

PMID: 40076851 PMC: 11900219. DOI: 10.3390/ijms26052229.


Unveiling the Interplay-Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2.

Wimalawansa S Biology (Basel). 2024; 13(10).

PMID: 39452140 PMC: 11504239. DOI: 10.3390/biology13100831.


Physiology of Vitamin D-Focusing on Disease Prevention.

Wimalawansa S Nutrients. 2024; 16(11).

PMID: 38892599 PMC: 11174958. DOI: 10.3390/nu16111666.


Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo.

Nilsen K, Zhang B, Skjesol A, Ryan L, Vagle H, Boe M Life Sci Alliance. 2023; 6(12).

PMID: 37788908 PMC: 10547912. DOI: 10.26508/lsa.202302164.


Lung Inflammation Induced by Inactivated SARS-CoV-2 in C57BL/6 Female Mice Is Controlled by Intranasal Instillation of Vitamin D.

Fernandes de Souza W, Zorzella-Pezavento S, Ayupe M, Salgado C, Oliveira B, Moreira F Cells. 2023; 12(7).

PMID: 37048165 PMC: 10093523. DOI: 10.3390/cells12071092.


References
1.
Gouni-Berthold I, Krone W, Berthold H . Vitamin D and cardiovascular disease. Curr Vasc Pharmacol. 2009; 7(3):414-22. DOI: 10.2174/157016109788340686. View

2.
Stevens S, Ciesielski T, Marsh B, Yang T, Homen D, Boule J . Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab. 2008; 28(5):1040-7. PMC: 3037270. DOI: 10.1038/sj.jcbfm.9600606. View

3.
Toli K, Paraskevas K, Poulakou M, Agrogiannis G, Kavantzas N, Xanthopoulos V . Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment?. Expert Opin Ther Targets. 2008; 12(10):1209-15. DOI: 10.1517/14728222.12.10.1209. View

4.
Goulopoulou S, McCarthy C, Webb R . Toll-like Receptors in the Vascular System: Sensing the Dangers Within. Pharmacol Rev. 2016; 68(1):142-67. PMC: 4709508. DOI: 10.1124/pr.114.010090. View

5.
Shea M, ODonnell C, Hoffmann U, Dallal G, Dawson-Hughes B, Ordovas J . Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr. 2009; 89(6):1799-807. PMC: 2682995. DOI: 10.3945/ajcn.2008.27338. View